$1.24 Billion in Sales Expected for CME Group Inc (NASDAQ:CME) This Quarter

Brokerages expect that CME Group Inc (NASDAQ:CME) will announce sales of $1.24 billion for the current fiscal quarter, Zacks reports. Five analysts have provided estimates for CME Group’s earnings. The lowest sales estimate is $1.16 billion and the highest is $1.28 billion. CME Group posted sales of $904.20 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 37.1%. The company is expected to announce its next quarterly earnings report before the market opens on Wednesday, October 30th.

According to Zacks, analysts expect that CME Group will report full-year sales of $4.92 billion for the current financial year, with estimates ranging from $4.84 billion to $5.03 billion. For the next year, analysts expect that the firm will report sales of $5.20 billion, with estimates ranging from $5.05 billion to $5.30 billion. Zacks’ sales averages are a mean average based on a survey of research firms that that provide coverage for CME Group.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.75 by $0.01. The firm had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The business’s revenue for the quarter was up 20.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.74 EPS.

A number of brokerages have issued reports on CME. UBS Group boosted their target price on CME Group from $214.00 to $220.00 and gave the company a “neutral” rating in a research report on Thursday. ValuEngine lowered CME Group from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Deutsche Bank boosted their target price on CME Group from $224.00 to $240.00 and gave the company a “buy” rating in a research report on Friday, August 9th. Berenberg Bank lowered CME Group from a “buy” rating to a “hold” rating and cut their target price for the company from $236.00 to $227.00 in a research report on Thursday, September 19th. Finally, BidaskClub raised CME Group from a “hold” rating to a “buy” rating in a research report on Friday, September 27th. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and seven have issued a buy rating to the company. CME Group presently has a consensus rating of “Hold” and a consensus price target of $200.43.

Shares of CME stock traded down $2.69 during trading on Wednesday, hitting $213.33. 774,020 shares of the stock traded hands, compared to its average volume of 1,546,092. The firm has a market capitalization of $75.00 billion, a P/E ratio of 31.28, a price-to-earnings-growth ratio of 4.45 and a beta of 0.20. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.05 and a quick ratio of 1.05. The firm’s fifty day moving average price is $213.72 and its 200-day moving average price is $195.66. CME Group has a 52-week low of $161.05 and a 52-week high of $224.91.

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th were paid a dividend of $0.75 per share. The ex-dividend date of this dividend was Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.41%. CME Group’s payout ratio is currently 43.99%.

In other CME Group news, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $200.15, for a total value of $7,005,250.00. Following the completion of the transaction, the chief executive officer now owns 79,057 shares in the company, valued at $15,823,258.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Sean Tully sold 7,200 shares of the company’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $223.13, for a total transaction of $1,606,536.00. Following the completion of the transaction, the insider now owns 19,923 shares of the company’s stock, valued at approximately $4,445,418.99. The disclosure for this sale can be found here. In the last quarter, insiders have sold 59,626 shares of company stock valued at $12,255,934. Insiders own 1.20% of the company’s stock.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CME. Buckingham Asset Management LLC raised its holdings in shares of CME Group by 1.4% in the second quarter. Buckingham Asset Management LLC now owns 3,607 shares of the financial services provider’s stock valued at $700,000 after buying an additional 49 shares during the last quarter. IHT Wealth Management LLC raised its holdings in shares of CME Group by 1.1% in the second quarter. IHT Wealth Management LLC now owns 4,404 shares of the financial services provider’s stock valued at $855,000 after buying an additional 50 shares during the last quarter. Pitcairn Co. raised its holdings in shares of CME Group by 2.3% in the second quarter. Pitcairn Co. now owns 2,239 shares of the financial services provider’s stock valued at $435,000 after buying an additional 51 shares during the last quarter. Lourd Capital LLC raised its holdings in shares of CME Group by 3.5% in the second quarter. Lourd Capital LLC now owns 1,620 shares of the financial services provider’s stock valued at $314,000 after buying an additional 55 shares during the last quarter. Finally, Garner Asset Management Corp raised its holdings in shares of CME Group by 1.1% in the second quarter. Garner Asset Management Corp now owns 5,200 shares of the financial services provider’s stock valued at $1,009,000 after buying an additional 55 shares during the last quarter. Institutional investors own 84.85% of the company’s stock.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Read More: S&P 500 Index

Get a free copy of the Zacks research report on CME Group (CME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.